Literature DB >> 28069485

Alternative approaches for identifying acute systemic toxicity: Moving from research to regulatory testing.

Jon Hamm1, Kristie Sullivan2, Amy J Clippinger3, Judy Strickland4, Shannon Bell4, Barun Bhhatarai5, Bas Blaauboer6, Warren Casey7, David Dorman8, Anna Forsby9, Natàlia Garcia-Reyero10, Sean Gehen11, Rabea Graepel12, Jon Hotchkiss5, Anna Lowit13, Joanna Matheson14, Elissa Reaves13, Louis Scarano15, Catherine Sprankle4, Jay Tunkel16, Dan Wilson5, Menghang Xia17, Hao Zhu18, David Allen4.   

Abstract

Acute systemic toxicity testing provides the basis for hazard labeling and risk management of chemicals. A number of international efforts have been directed at identifying non-animal alternatives for in vivo acute systemic toxicity tests. A September 2015 workshop, Alternative Approaches for Identifying Acute Systemic Toxicity: Moving from Research to Regulatory Testing, reviewed the state-of-the-science of non-animal alternatives for this testing and explored ways to facilitate implementation of alternatives. Workshop attendees included representatives from international regulatory agencies, academia, nongovernmental organizations, and industry. Resources identified as necessary for meaningful progress in implementing alternatives included compiling and making available high-quality reference data, training on use and interpretation of in vitro and in silico approaches, and global harmonization of testing requirements. Attendees particularly noted the need to characterize variability in reference data to evaluate new approaches. They also noted the importance of understanding the mechanisms of acute toxicity, which could be facilitated by the development of adverse outcome pathways. Workshop breakout groups explored different approaches to reducing or replacing animal use for acute toxicity testing, with each group crafting a roadmap and strategy to accomplish near-term progress. The workshop steering committee has organized efforts to implement the recommendations of the workshop participants.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3Rs; Acute systemic toxicity; Alternatives; Dermal; In silico; In vitro; Inhalation; LD(50); Oral

Mesh:

Year:  2017        PMID: 28069485      PMCID: PMC5479748          DOI: 10.1016/j.tiv.2017.01.004

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  34 in total

Review 1.  Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment.

Authors:  Gerald T Ankley; Richard S Bennett; Russell J Erickson; Dale J Hoff; Michael W Hornung; Rodney D Johnson; David R Mount; John W Nichols; Christine L Russom; Patricia K Schmieder; Jose A Serrrano; Joseph E Tietge; Daniel L Villeneuve
Journal:  Environ Toxicol Chem       Date:  2010-03       Impact factor: 3.742

Review 2.  Dose metric considerations in in vitro assays to improve quantitative in vitro-in vivo dose extrapolations.

Authors:  Floris A Groothuis; Minne B Heringa; Beate Nicol; Joop L M Hermens; Bas J Blaauboer; Nynke I Kramer
Journal:  Toxicology       Date:  2013-08-23       Impact factor: 4.221

Review 3.  Acute toxicity testing of chemicals-Opportunities to avoid redundant testing and use alternative approaches.

Authors:  Stuart Creton; Ian C Dewhurst; Lesley K Earl; Sean C Gehen; Robert L Guest; Jon A Hotchkiss; Ian Indans; Michael R Woolhiser; Richard Billington
Journal:  Crit Rev Toxicol       Date:  2010-01       Impact factor: 5.635

4.  MEIC Evaluation of Acute Systemic Toxicity: Part VI. The Prediction of Human Toxicity by Rodent LD50 Values and Results From 61 In Vitro Methods.

Authors:  B Ekwall; F A Barile; A Castano; C Clemedson; R H Clothier; P Dierickx; B Ekwall; M Ferro; G Fiskesjö; L Garza-Ocañas; M J Gómez-Lechón; M Gülden; T Hall; B Isomaa; A Kahru; G Kerszman; U Kristen; M Kunimoto; S Kärenlampi; L Lewan; A Loukianov; T Ohno; G Persoone; L Romert; T W Sawyer; R Shrivastava; H Segner; A Stammati; N Tanaka; M Valentino; E Walum; F Zucco
Journal:  Altern Lab Anim       Date:  1998-08       Impact factor: 1.303

5.  Selection of test methods to be included in a testing strategy to predict acute oral toxicity: an approach based on statistical analysis of data collected in phase 1 of the ACuteTox project.

Authors:  A Kinsner-Ovaskainen; P Prieto; S Stanzel; A Kopp-Schneider
Journal:  Toxicol In Vitro       Date:  2012-11-21       Impact factor: 3.500

6.  Assessment of the predictive capacity of the 3T3 Neutral Red Uptake cytotoxicity test method to identify substances not classified for acute oral toxicity (LD50>2000 mg/kg): results of an ECVAM validation study.

Authors:  Pilar Prieto; Thomas Cole; Rodger Curren; Rosemary M Gibson; Manfred Liebsch; Hans Raabe; Anita M Tuomainen; Maurice Whelan; Agnieszka Kinsner-Ovaskainen
Journal:  Regul Toxicol Pharmacol       Date:  2012-12-13       Impact factor: 3.271

7.  Exploring waiving opportunities for mammalian acute systemic toxicity tests.

Authors:  Rabea Graepel; David Asturiol; Pilar Prieto; Andrew P Worth
Journal:  Altern Lab Anim       Date:  2016-07       Impact factor: 1.303

8.  Acute Toxicity Prediction in Multiple Species by Leveraging Mechanistic ToxCast Mitochondrial Inhibition Data and Simulation of Oral Bioavailability.

Authors:  Barun Bhhatarai; Daniel M Wilson; Michael J Bartels; Shubhra Chaudhuri; Paul S Price; Edward W Carney
Journal:  Toxicol Sci       Date:  2015-07-02       Impact factor: 4.849

9.  Evaluation of aggregating brain cell cultures for the detection of acute organ-specific toxicity.

Authors:  Marie-Gabrielle Zurich; Sven Stanzel; Annette Kopp-Schneider; Pilar Prieto; Paul Honegger
Journal:  Toxicol In Vitro       Date:  2012-08-29       Impact factor: 3.500

Review 10.  Big data in chemical toxicity research: the use of high-throughput screening assays to identify potential toxicants.

Authors:  Hao Zhu; Jun Zhang; Marlene T Kim; Abena Boison; Alexander Sedykh; Kimberlee Moran
Journal:  Chem Res Toxicol       Date:  2014-09-16       Impact factor: 3.739

View more
  13 in total

Review 1.  Status of acute systemic toxicity testing requirements and data uses by U.S. regulatory agencies.

Authors:  Judy Strickland; Amy J Clippinger; Jeffrey Brown; David Allen; Abigail Jacobs; Joanna Matheson; Anna Lowit; Emily N Reinke; Mark S Johnson; Michael J Quinn; David Mattie; Suzanne C Fitzpatrick; Surender Ahir; Nicole Kleinstreuer; Warren Casey
Journal:  Regul Toxicol Pharmacol       Date:  2018-02-03       Impact factor: 3.271

2.  Alternative approaches for acute inhalation toxicity testing to address global regulatory and non-regulatory data requirements: An international workshop report.

Authors:  Amy J Clippinger; David Allen; Annie M Jarabek; Marco Corvaro; Marianna Gaça; Sean Gehen; Jon A Hotchkiss; Grace Patlewicz; Jodie Melbourne; Paul Hinderliter; Miyoung Yoon; Dongeun Huh; Anna Lowit; Barbara Buckley; Michael Bartels; Kelly BéruBé; Daniel M Wilson; Ian Indans; Mathieu Vinken
Journal:  Toxicol In Vitro       Date:  2017-12-22       Impact factor: 3.500

3.  Prediction of drug-induced liver injury and cardiotoxicity using chemical structure and in vitro assay data.

Authors:  Lin Ye; Deborah K Ngan; Tuan Xu; Zhichao Liu; Jinghua Zhao; Srilatha Sakamuru; Li Zhang; Tongan Zhao; Menghang Xia; Anton Simeonov; Ruili Huang
Journal:  Toxicol Appl Pharmacol       Date:  2022-09-20       Impact factor: 4.460

4.  Multiple metabolic pathways are predictive of ricin intoxication in a rat model.

Authors:  Riccardo V D'Elia; Sarah A Goodchild; Catherine L Winder; Andrew D Southam; Ralf J M Weber; Fiona M Stahl; Cerys Docx; Vikesh Patel; A Christopher Green; Mark R Viant; Roman A Lukaszewski; Warwick B Dunn
Journal:  Metabolomics       Date:  2019-07-03       Impact factor: 4.290

5.  A cross-industry collaboration to assess if acute oral toxicity (Q)SAR models are fit-for-purpose for GHS classification and labelling.

Authors:  Joel Bercu; Melisa J Masuda-Herrera; Alejandra Trejo-Martin; Catrin Hasselgren; Jean Lord; Jessica Graham; Matthew Schmitz; Lawrence Milchak; Colin Owens; Surya Hari Lal; Richard Marchese Robinson; Sarah Whalley; Phillip Bellion; Anna Vuorinen; Kamila Gromek; William A Hawkins; Iris van de Gevel; Kathleen Vriens; Raymond Kemper; Russell Naven; Pierre Ferrer; Glenn J Myatt
Journal:  Regul Toxicol Pharmacol       Date:  2020-12-17       Impact factor: 3.271

6.  Harnessing the power of novel animal-free test methods for the development of COVID-19 drugs and vaccines.

Authors:  Francois Busquet; Thomas Hartung; Giorgia Pallocca; Costanza Rovida; Marcel Leist
Journal:  Arch Toxicol       Date:  2020-05-23       Impact factor: 5.153

Review 7.  An Overview of In Vitro, In Vivo, and Computational Techniques for Cancer-Associated Angiogenesis Studies.

Authors:  Heshu Sulaiman Rahman; Bee Ling Tan; Hemn Hassan Othman; Max Stanley Chartrand; Yashwant Pathak; Syam Mohan; Rasedee Abdullah; Noorjahan Banu Alitheen
Journal:  Biomed Res Int       Date:  2020-12-10       Impact factor: 3.411

8.  Advances in acute toxicity testing: strengths, weaknesses and regulatory acceptance.

Authors:  Earnest Oghenesuvwe Erhirhie; Chibueze Peter Ihekwereme; Emmanuel Emeka Ilodigwe
Journal:  Interdiscip Toxicol       Date:  2018-08-06

9.  Differences in biocompatibility of microneedles from cyclic olefin polymers with human endothelial and epithelial skin cells.

Authors:  Klaudia Schossleitner; Conor O'Mahony; Stefan Brandstätter; Michael J Haslinger; Sabrina Demuth; Daniel Fechtig; Peter Petzelbauer
Journal:  J Biomed Mater Res A       Date:  2018-11-19       Impact factor: 4.396

10.  Use of LUCS (Light-Up Cell System) as an alternative live cell method to predict human acute oral toxicity.

Authors:  C Gironde; C Dufour; C Furger
Journal:  Toxicol Rep       Date:  2020-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.